AXSM
Axsome Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$206.68
−0.80%Forward multiples
Based on analyst estimates
- P/E forward
- 1233.12x
- P/E 2026E
- —
- P/E 2027E
- 44.52x
- P/E 2028E
- 16.51x
- P/S forward
- 9.03x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 129.96x
- Price / sales
- 13.94x
- Price / cash flow
- -151.93x
Enterprise value
- Enterprise value
- $10.7B
- EV / sales
- 13.81x
- EV / EBITDA
- -59.65x
- EV / EBIT
- -56.89x
- Market cap
- $10.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026